Anna Protopapas

Anna Protopapas

Presidente en NUVALENT, INC. .

Fortuna: 948 250 $ al 31/05/2026

61 años
Health Technology
Consumer Services
Process Industries

Perfil

Ms. Anna Protopapas is a Chief Executive Officer & Director at Flare Therapeutics, Inc. and an Independent Chairman at Nuvalent, Inc. She is on the Board of Directors at Flare Therapeutics, Inc. Ms. Protopapas was previously employed as an Independent Director by Dicerna Pharmaceuticals, Inc., an Independent Director by ARIAD Pharmaceuticals, Inc., an Executive VP-Global Business Development by Takeda Pharmaceutical Co., Ltd., a Head-Global Business Development by Takeda Pharmaceuticals International, Inc., and a President & Chief Executive Officer by Takeda Oncology Co. She also served on the board at Bioverativ, Inc., Mersana Therapeutics, Inc. and Ensemble Therapeutics Corp.
She received her undergraduate degree from Princeton University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/06/2026 8.590 ( 0,01 % ) 948 250 $ 31/05/2026
06/01/2026 0 ( -.--% ) - $ 31/12/2025

Cargos activos de Anna Protopapas

EmpresasCargoInicio
NUVALENT, INC. Presidente 30/03/2022
Director Ejecutivo 30/06/2026

Antiguos cargos conocidos de Anna Protopapas.

EmpresasCargoFin
MERSANA THERAPEUTICS Director Ejecutivo 10/09/2023
DICERNA PHARMACEUTICALS, INC. Director/Miembro de la Junta 03/06/2021
BIOVERATIV INC Director/Miembro de la Junta 08/03/2018
ARIAD PHARMACEUTICALS, INC. Director/Miembro de la Junta 16/01/2017
Corporate Officer/Principal 01/10/2014
Ver el detalle de la experiencia de Anna Protopapas.

Formación de Anna Protopapas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

83

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology